Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhancing screening adherence for strongyloides infection in latinx inpatients with COVID-19: a local protocol implementation study.
Pérez-Jacoiste Asín MA, De Castro M, De Dios B, Pérez-Ayala A, Lalueza A, García-Reyne A, Losada I, Herrero-Martínez JM, Jiménez PH, Lumbreras C, Lizasoain M, López Medrano F. Pérez-Jacoiste Asín MA, et al. Pathog Glob Health. 2023 Jul 31:1-9. doi: 10.1080/20477724.2023.2240088. Online ahead of print. Pathog Glob Health. 2023. PMID: 37525476
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study.
Fernández-Ruiz M, López-Medrano F, Pérez-Jacoiste Asín MA, Maestro de la Calle G, Bueno H, Caro-Teller JM, Catalán M, de la Calle C, García-García R, Gómez C, Laguna-Goya R, Lizasoáin M, Martínez-López J, Origüen J, Pablos JL, Ripoll M, San Juan R, Trujillo H, Lumbreras C, Aguado JM. Fernández-Ruiz M, et al. J Med Virol. 2021 Feb;93(2):831-842. doi: 10.1002/jmv.26308. Epub 2020 Jul 27. J Med Virol. 2021. PMID: 32672860 Free PMC article.
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study.
de la Calle C, López-Medrano F, Pablos JL, Lora-Tamayo J, Maestro-de la Calle G, Sánchez-Fernández M, Fernández-Ruiz M, Pérez-Jacoiste Asín MA, Caro-Teller JM, García-García R, Catalán M, Martínez-López J, Sevillano Á, Origüen J, Ripoll M, San Juan R, Lalueza A, de Miguel B, Carretero O, Aguilar F, Gómez C, Paz-Artal E, Bueno H, Lumbreras C, Aguado JM. de la Calle C, et al. Among authors: perez jacoiste asin ma. Int J Infect Dis. 2021 Apr;105:319-325. doi: 10.1016/j.ijid.2021.02.041. Epub 2021 Feb 13. Int J Infect Dis. 2021. PMID: 33592340 Free PMC article.
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study.
López-Medrano F, Pérez-Jacoiste Asín MA, Fernández-Ruiz M, Carretero O, Lalueza A, Maestro de la Calle G, Caro JM, de la Calle C, Catalán M, García-García R, Martínez-López J, Origüen J, Ripoll M, San Juan R, Trujillo H, Sevillano Á, Gutiérrez E, de Miguel B, Aguilar F, Gómez C, Silva JT, García-Ruiz de Morales D, Saro-Buendía M, Marrero-Sánchez Á, Chiara-Graciani G, Bueno H, Paz-Artal E, Lumbreras C, Pablos JL, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group. López-Medrano F, et al. Among authors: perez jacoiste asin ma. Int J Infect Dis. 2021 Apr;105:487-494. doi: 10.1016/j.ijid.2021.02.099. Epub 2021 Feb 26. Int J Infect Dis. 2021. PMID: 33647515 Free PMC article.
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19.
San-Juan R, Fernández-Ruiz M, López-Medrano F, Carretero O, Lalueza A, Maestro de la Calle G, Pérez-Jacoiste Asín MA, Bueno H, Caro-Teller JM, Catalán M, de la Calle C, García-García R, Gómez C, Laguna-Goya R, Lizasoáin M, Martínez-López J, Origüen J, Sevillano Á, Gutiérrez E, de Miguel B, Aguilar F, Parra P, Ripoll M, Ruiz-Merlo T, Trujillo H, Pablos JL, Paz-Artal E, Lumbreras C, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group, the Spanish Network for Research in Infectious Diseases (REIPI). San-Juan R, et al. Among authors: perez jacoiste asin ma. Int J Infect Dis. 2022 Apr;117:56-64. doi: 10.1016/j.ijid.2022.01.040. Epub 2022 Jan 23. Int J Infect Dis. 2022. PMID: 35081417 Free PMC article.
Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods.
López-Medrano F, Muñoz de la Espada M, Pérez-Jacoiste Asín MA, Fernández-Ruiz M, Herrero-Martínez JM, Alonso-Carrillo J, San Juan R, Rodríguez-Goncer I, Andrés A, González E, Manrique A, Justo I, Marcacuzco A, Loinaz C, Jiménez C, Lumbreras C, Aguado JM. López-Medrano F, et al. Among authors: perez jacoiste asin ma. Mycoses. 2022 May;65(5):517-525. doi: 10.1111/myc.13436. Epub 2022 Mar 15. Mycoses. 2022. PMID: 35262977
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
Pérez-Jacoiste Asín MA, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Tejido Á, San Juan R, Arrebola-Pajares A, Lizasoain M, Prieto S, Aguado JM. Pérez-Jacoiste Asín MA, et al. Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119. Medicine (Baltimore). 2014. PMID: 25398060 Free PMC article. Review.
A joint program of antimicrobial stewardship and hospital-acquired infection control to reduce healthcare-associated infections after kidney transplantation: The Hipomenes study.
Silva JT, Montoro J, Pérez-Jacoiste Asín MA, Fernández-Ruiz M, Polanco N, González E, Caro-Teller JM, Andrés A, Aguado JM, López-Medrano F. Silva JT, et al. Among authors: perez jacoiste asin ma. Am J Transplant. 2023 Dec;23(12):1949-1960. doi: 10.1016/j.ajt.2023.07.009. Epub 2023 Jul 20. Am J Transplant. 2023. PMID: 37479034
30 results